Crawford Investment Counsel’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Crawford Investment Counsel's LMAT Position: Q2 2026 in Review
Crawford Investment Counsel increased its LeMaitre Vascular (LMAT) stake by 2% in Q2 2026, buying an estimated $225K and bringing the position to 114,066 shares worth $10.9M. The position accounts for 0.18% of the portfolio, ranked #104.
Crawford Investment Counsel first reported a position in LMAT in Q2 2022 and has held it in 17 quarters since. The position peaked at $12.2M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Crawford Investment Counsel held 114,066 shares of LeMaitre Vascular worth $10.9M as of Q2 2026.
- Crawford Investment Counsel bought 2,190 LeMaitre Vascular shares in Q2 2026, an estimated $225K.
- LeMaitre Vascular made up 0.18% of Crawford Investment Counsel's portfolio in Q2 2026, its #104 holding.
- Crawford Investment Counsel first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 17 quarters since.
- Crawford Investment Counsel's LeMaitre Vascular position peaked at $12.2M in Q1 2026.
- 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Crawford Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.